Latest Articles
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells - News-Medical
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells News-Medical
Published: Nov. 27, 2025, 10:29 a.m.
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer - OncLive
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer OncLive
Published: Nov. 26, 2025, 7:03 p.m.
NICE recommends treatment for primary advanced or recurrent endometrial cancer - Pf Media
NICE recommends treatment for primary advanced or recurrent endometrial cancer Pf Media
Published: Nov. 26, 2025, 4:10 p.m.
‘ER’ Star Alex Kingston, 62, Says After Battling Uterine Cancer, She’s Become ‘Fearless’ - SurvivorNet
‘ER’ Star Alex Kingston, 62, Says After Battling Uterine Cancer, She’s Become ‘Fearless’ SurvivorNet
Published: Nov. 26, 2025, 3:57 p.m.
Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts - Inshorts
Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts Inshorts
Published: Nov. 26, 2025, 11:03 a.m.
A STEM educator battles rare endometrial cancer - UT Physicians
A STEM educator battles rare endometrial cancer UT Physicians
Published: Nov. 25, 2025, 9:25 p.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 25, 2025, 2:06 p.m.
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women - Frontiers
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women Frontiers
Published: Nov. 24, 2025, 8:22 p.m.
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer - NAVLIN DAILY
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 24, 2025, 12:18 p.m.
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer - Oncodaily
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer Oncodaily
Published: Nov. 21, 2025, 4:19 p.m.
Link copied to clipboard!